Treatment Therapies in Pancreatic Carcinoma

Pancreatic cancer is the fourth leading cause of cancer deaths, being responsible for 7% of all cancer-related deaths in both men and women. Approximately 75% of all pancreatic carcinomas occur within the head or neck of the pancreas, 15-20% occurs in the body of the pancreas, and 5-10% occurs in the tail. Scientists are learning more about some of the changes in DNA that cause cells in the pancreas to become cancerous. Inherited changes in genes such as BRCA2, p16, and the genes responsible for hereditary non-polyposis colorectal cancer (HNPCC) can increase a person’s risk of developing pancreatic cancer.

  • Proton therapy
  • Radiation therapy
  • Chemotherapy
  • Immunotherapy
  • Ablation or embolization treatments

Related Conference of Treatment Therapies in Pancreatic Carcinoma

March 10-11, 2025

8th International Congress on Viral Hepatitis

Paris, France
March 13-14, 2025

13th International Conference on Gynecology and Obstetrics

Prague, Czech Republic
March 24-25, 2025

16th International Conference on Liver Diseases & Hepatology

London, UK
March 24-25, 2025

19th World Congress on Gastroenterology -Therapeutics & Hepatology

Dubai, UAE
April 14-15, 2025

25th International Conference on Gastroenterology and Hepatology

Budapest, Hungary
June 04-05, 2025

25th International Conference on Gastroenterology and Hepatology

Edinburgh, Scotland
July 07-08, 2025

20th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 30-31, 2025

4th International Conference on Gastroenterology and Liver

Paris, France
August 21-22, 2025

6th Global Summit on Earth Science and Climate Change

Paris, France
September 29-30, 2025

7th International Conference on Gastroenterology and Liver Diseases

Paris, France
October 20-21, 2025

24th International Conference on Gastroenterology and Digestive Disorders

Osaka, Japan

Treatment Therapies in Pancreatic Carcinoma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in